Reclassification of C4d-positive Endomyocardial Biopsy (EMB) according to new International Society for Heart and Lung Transplantation (ISHLT) 2013 categories for reporting pathologic Antibody-Mediated Rejection (pAMR): Preliminary data from a polish single-center study

Annals of Transplantation

Volumn 20, Issue , 2015, Pages 351-356

  Szymańska, Sylwia ^a   Grajkowska, Wiesława ^a   Sobieszczańska Małek, Małgorzata ^b   Zieliński, Tomasz ^b   Pronicki, Maciej ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Biopsy; Graft rejection; Heart transplantation; Pathology

Indexed keywords

COMPLEMENT COMPONENT C4D; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; CELL INFILTRATION; FEMALE; HEART LUNG TRANSPLANTATION; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE; LUNG EDEMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SWELLING; BIOPSY; CARDIAC MUSCLE; EDEMA; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; POLAND; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; COMPLEMENT C4B; EDEMA; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PEPTIDE FRAGMENTS; POLAND; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84933500064     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.893635     Document Type: Article

References (20)

1. Berry GJ, Angelini A, Burke MM et al: The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant, 2011; 30: 601-11
2. Stewart S, Winters GL, Fishbein MC et al: Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant, 2005; 24: 1710-20
3. Feucht H, Opelz G: The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int, 1996; 50: 1464-75
4. Behr TM, Feucht HE, Richter K et al: Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant, 1999; 18(9): 904-12
5. Takemoto SK, Zeevi A, Feng S et al: National conference to assess antibodymediated rejection In solid organ transplantation. Am J Trnasplant, 2004; 4: 1033-41
6. Kfoury AG, Renlund DG, Snow GL et al: A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant, 2009; 28: 51-57
7. Wu GW, Kobashigawa JA, Fishbein MC et al: Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcome. J Heart Lung Transplant, 2009; 28: 417-22
8. Berry GJ, Burke MM, Anderson C et al: The 2013 International Society for Heart and Lung Transplantation Working Formulation for standarization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Transplant, 2013; (32)12: 1147-61
9. Stewart S, Fishbein MC, Snell GI et al: Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant, 2007; 26(12): 1229-42
10. Kfoury AG, Hammond ME, Snow GL et al: Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 2009; 28: 781-84
11. Urbanowicz T, Baszyńska-Wachowiak H, Ligowski M et al: Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. Ann Transplant, 2014; 19: 295-99
12. Wasowska BA: Mechanisms involved in antibody-and complement-mediated allograft rejection. Immunol Res, 2010; 47(1-3): 25-44
13. Kirk AD, Morrell CN, Baldwin WM III: Platelets influence vascularized organ transplants from start to finish. Am J Transpl, 2009; 9: 14-22
14. Morrell CN, Sun H, Swaim AM, Baldwin WM III: Platelets an inflammatory force in transplantation. Am J Transpl, 2007; 7: 2447-54
15. Lindenfeld JA, Miller GG, Shakar SF et al: New drugs and technologies drug therapy in the heart transplant recipient part I: cardiac rejection and immunosuppressive drugs. Circulation, 2004; 110: 3734-40
16. Behrendt D, Ganz P, Fang JC: Cardiac allograft vasculopathy. Curr Opin Cardiol, 2000; 15: 422-29
17. Young JB: Perspectives on cardiac allograft vasculopathy. Curr Atheroscler Rep, 2000; 2: 259-71
18. Urbanowicz T, Kociemba A, Pyda M et al: Cardiovascular magnetic resonance imaging in asymptomatic acute heart rejection: a case report. Ann Transplant, 2014; 19: 447-51
19. Hammond EH, Yowell RL, Nunoda S et al: Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant, 1989; 8: 430-43
20. Gopal S, Narasimhan U, Day JD et al: The Quilty lesion enigma: focal apoptosis/ necrosis and lymphocyte subsets in human cardiac allografts. Pathol Int, 1998; 48(3): 191-98